Retatrutide is an investigational peptide currently being studied for its potential in metabolic research
The 30-year-old from Phoenix, Arizona, who had struggled with an eating disorder, admitted: I thought I needed Ozempic to be beautiful and successful. In phase two trials involving 338 obese participants, women on retatrutide lost an average of 28.5% of their body weight over 48 weeks, while men lost an average of 21.2%
The majority experienced minor to moderate gastrointestinal issues such as nausea, diarrhea, or vomiting
IF YOU HAVE NOT PURCHASED THIS PRODUCT BEFORE, YOU WILL BE CONTACTED BY ONE OF OUR NATUROPATHS TO AUTHORISE THIS PRODUCT IS CORRECT FOR YOU
Zunveyl was designed to eliminate drug absorption in the GI tract, potentially addressing tolerability issues with leading Alzheimers drugs, according to Alpha Cognition